adidas Celebrates 20 Years of its Iconic TOUR360 Footwear Franchise
The commemorative model offers a modern update on the historic version that…
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
CAMBRIDGE, Mass., Nov. 12, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc., previously known as…
BPGbio Appoints John Dvor as Executive Vice President, Corporate Development
BOSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered,…
Phoenix Aviation Capital and AIP Capital Announce Issuance of a $592 Million Term Loan Facility
DUBLIN and STAMFORD, Conn. and NEW YORK, Nov. 10, 2025 /PRNewswire/ --…
Sapphire Sport Becomes 359 Capital
Backed by iconic LPs across sports, media, and entertainment, 359 Capital will…
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable…
Bitget Launches Institutional Financing Program Offering Interest-Free 2M USDT to Boost Altcoin Liquidity
VICTORIA, Seychelles, Nov. 4, 2025 /PRNewswire/ -- Bitget, the world's largest Universal…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…
Novo Tellus completes its transformative growth partnership with Grand Venture Technology
Grand Venture Technology embarks on the next chapter of global growth as…